摘要
目的:研究血清促甲状腺激素在甲状腺微小癌中的表达以及临床上的诊断价值。方法:收治甲状腺结节患者260例,对患者手术前的血清促甲状腺激素检查、手术记录等进行统计、分析。结果:甲状腺良性结节患者血清促甲状腺激素的浓度低于分化型甲状腺癌(P<0.05)。结论:由于甲状腺微小癌患者的血清促甲状腺激素浓度与良性之间的差异没有统计学意义,还不能作为甲状腺微小癌的风险评估预测指标。
Objective:To research the expression and clinical value of serum thyroid stimulating hormone in thyroid cancer.Methods:260 patients with thyroid nodules were selected,statistical analysis of serum thyroid stimulating hormone test,operation record,etc..Results:The concentration of serum thyroid stimulating hormone was lower than that of differentiated thyroid carcinoma(P<0.05).Conclusion:Because there is no significant difference between the serum thyroid stimulating hormone concentrations and benign thyroid cancer patients,it can not be used as a predictive indicator of thyroid cancer risk.
作者
赵磊
李志军
艾杨卿
Zhao Lei;Li Zhijun;Ai Yangqing(The First Department of General Surgery,the People's Hospital of Baoshan City,Yunnan Province 678000)
出处
《中国社区医师》
2016年第1期104-105,共2页
Chinese Community Doctors
关键词
促甲状腺激素
甲状腺微小乳头癌
分化型甲状腺癌
Thyroid stimulating hormone
Thyroid papillary carcinoma
Differentiated thyroid carcinoma
